이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth

2012년 5월 31일 업데이트: University of Pennsylvania

The number of youth with Type 2 diabetes (T2D) is rising in the population, which is a concerning public health trend. There has been little research testing ways to prevent the development of this disease in children who are at increased risk to develop T2D. This study tests a family treatment program that treats 4-8 year old children who are at risk for T2D because they are overweight and have a family history of the disease. Sixty at risk children and their parents were assigned to one of 2 treatment conditions. Half of the families (randomly determined) received an intensive family treatment program that trains parents in how to increase healthier foods choices and physical activity for themselves and their children using "behavior modification" strategies. Children receiving this treatment were allowed to taste new fruits and vegetables used a pedometer to record how far they walked every day, and were given a "tool box" of toys and interactive games which promoted physical activity. The other half of the families only received instruction about healthier choices, but received no behavioral modification strategies or physical activity promotion tools. Improvements in children's body weight, blood measures, and behavior patterns were measured after treatment ended (6 months) and then again after 12 months. The results may lead to a better understanding of how family members can positively influence young children's behaviors to help prevent T2D. The objective of proposed study was to test a family-based intervention designed to reduce excess body weight, improve metabolic and cardiovascular profile, and improve diet and physical activity levels in 4 - 8 year old youth who are "at risk" for T2D. This intervention was tested in a 2-arm randomized controlled clinical trial.

Primary Hypotheses:

  1. Compared to children receiving NPA, children receiving LMDP will show greater reductions in excess body weight, greater improvements in metabolic and cardiovascular measures, improved diet, increased physical activity, and reduced television viewing.
  2. Greater reductions in child excess body weight will be associated with greater improvements in metabolic and cardiovascular measures.

Secondary Hypotheses:

  1. Compared to parents receiving the NPA intervention, parents receiving the LMDP intervention will show greater reductions in BMI.
  2. Greater improvements in parent BMI will be associated with greater improvements in child body composition, metabolic and cardiovascular measures, and behavioral outcomes.
  3. Compared to families receiving the NPA intervention, families receiving the LMDP intervention will show an increase in the number of fruits and vegetables and lower energy density foods stored at home.

연구 개요

상세 설명

There is mounting concern about the development of Type 2 diabetes (T2D) in youth, especially in light of rising childhood obesity rates at younger ages. The health costs of T2D are notable both for the individual and society, and so interventions that can help prevent the development of T2D in early life are needed. Fortunately, there is promising evidence from the Diabetes Prevention Program (DPP) and other randomized trials with adults that the onset of T2D can be prevented through sustainable lifestyle changes. However, intervention programs have not been tested in young children who are "at risk" for developing the disease, even though this may be a critical period for obesity onset and for the formation of early eating and physical activity habits.

The primary aim of the proposed study was to test a family-based intervention that targets improvements in excess weight gain, metabolic and cardiovascular profile, and diet and physical activity in 4 - 8 year old children who are "at risk" for T2D. Specifically, 60 families were randomized either to one of two treatments: Lifestyle Modification for Diabetes Prevention (LMDP, N= 30) or Nutrition and Physical Activity Information (NPA, N= 30). The LMDP intervention trained families in behavioral strategies to increase parent and child intake of fruits, vegetables, and high fiber foods, to limit intake of energy-dense foods, and to increase daily physical activity. A physical activity "tool kit" for the home environment was provided to families. Supporting information about T2D and obesity, as well as nutrition and physical activity, also were provided. Besides the participating parent-child pair, other adult family members with T2D (eg, grandparents, aunts, uncles) were encouraged to participate. The LMDP activities were intended to reduce children's excess body weight and improve their metabolic and cardiovascular measures, to help prevent the onset of insulin resistance. The NPA intervention only received basic information on T2D and obesity, and nutrition and physical activity recommendations. Changes in child body composition, metabolic and cardiovascular measures, and behavioral outcomes were evaluated at 6 months (ie, end-of-treatment) and 12 months (ie, follow up). Changes in parent weight status and the home food environment were secondary outcomes and were assessed as potential mediators of child outcomes.

연구 유형

중재적

등록 (실제)

52

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Pennsylvania
      • Philadelphia, Pennsylvania, 미국, 19104
        • University of Pennsylvania Center for Weight and Eating Disorders/Perelman School of Medicine

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

4년 (어린이)

건강한 자원 봉사자를 받아들입니다

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Age 4-8 years old
  • Age- and sex-specific BMI ≥95th percentile

Exclusion Criteria:

  • Children with serious medical conditions
  • Children who show signs of elevated psychopathology, as assessed by the Child Behavior Checklist (CBCL)
  • Children of parents with significantly elevated psychiatric disorders

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: Lifestyle Modification for Diabetes Prevention
Family based intervention utilizing Traffic Light Diet, self monitoring, parent behavioral skill training and tool kit of items promoting physical activity.
Family based behavioral intervention utilizing Traffic Light Diet, self monitoring, goal setting, reinforcement and a tool kit containing physical activity-promoting items
다른: Nutrition and Physical Activity
Family based intervention providing education on healthy eating and physical activity but no behavioral skills training, goal setting, self monitoring or physical activity toolkit.
This family based education program provided information on physical activity and healthy eating for parents and children.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Body Mass Index (BMI)
기간: Baseline, 6 and 12 months
Change in BMI will be measured from baseline to end of intervention (6 months) and and also from 6 months to 12 months.
Baseline, 6 and 12 months
BMI-z score
기간: Baseline, 6 and 12 months
Change in BMI-z score will be measured from baseline to end of treatment (6 months) and from 6 months to 12 months.
Baseline, 6 and 12 months
Percent overweight (% overweight)
기간: Baseline, 6 and 12 months
Change in percent overweight will be measured from baseline to end of treatment (6 months) and from 6 months to 12 months. Percent overweight is computed as a child's actual BMI minus the median BMI for a child of comparable sex and age, divided by 100.
Baseline, 6 and 12 months
Waist Circumference(cm)
기간: Baseline, 6 and 12 months
Change in waist circumference (cm) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Baseline, 6 and 12 months
Systolic Blood Pressure
기간: Baseline, 6 and 12 months
Change in systolic blood pressure (mm Hg) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Baseline, 6 and 12 months
Diastolic Blood Pressure (mm Hg)
기간: Baseline, 6 and 12 months
Change in diastolic blood pressure (mm Hg) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Baseline, 6 and 12 months
Pulse
기간: Baseline, 6 and 12 months
Change in resting pulse will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Baseline, 6 and 12 months
Physical Activity
기간: Baseline, 6 and 12 months
Change in physical activity was measured from baseline to end of treatment (6 months) and from end of treatment to 12 months using an accelerometer. The accelerometer measured light, moderate and moderate-to-vigorous actity over 7 days.
Baseline, 6 and 12 months
Glucose
기간: Baseline, 6 and 12 months
Change in blood glucose levels were measured at baseline, 6 and 12 months.
Baseline, 6 and 12 months
Insulin
기간: Baseline, 6 and 12 months
Change in plasma insulin levels from baseline to end of treatment (6 months) and from 6 months to 12 months.
Baseline, 6 and 12 months
Change in HDL, LDL, Total Cholesterol and Triglycerides
기간: Baseline, 6 and 12 months
Change in lipid profile measures from baseline to end of treatment (6 months) and from 6 months to 12 months.
Baseline, 6 and 12 months
Change in Dietary Intake
기간: Baseline, 6 and 12 months
Change in energy (kcals/day), protein, carbohydrate, fat, cholesterol, saturated fat and fiber intake.
Baseline, 6 and 12 months

2차 결과 측정

결과 측정
측정값 설명
기간
Change in Parent BMI
기간: Baseline, 6 and 12 months
Change in parent BMI from baseline to end of treatment (6 months) and from 6 motnths to 12 months.
Baseline, 6 and 12 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Myles S Faith, Ph.D., University of Pennsylvania

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2008년 8월 1일

기본 완료 (실제)

2011년 1월 1일

연구 완료 (실제)

2011년 1월 1일

연구 등록 날짜

최초 제출

2012년 5월 30일

QC 기준을 충족하는 최초 제출

2012년 5월 31일

처음 게시됨 (추정)

2012년 6월 1일

연구 기록 업데이트

마지막 업데이트 게시됨 (추정)

2012년 6월 1일

QC 기준을 충족하는 마지막 업데이트 제출

2012년 5월 31일

마지막으로 확인됨

2012년 5월 1일

추가 정보

이 연구와 관련된 용어

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

3
구독하다